Tudor Investment Corp ET AL Invests $2.25 Million in Bausch + Lomb Corporation $BLCO

Tudor Investment Corp ET AL purchased a new position in shares of Bausch + Lomb Corporation (NYSE:BLCO) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 149,270 shares of the company’s stock, valued at approximately $2,249,000.

Several other hedge funds also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. lifted its stake in Bausch + Lomb by 729.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,322 shares of the company’s stock worth $30,000 after purchasing an additional 2,042 shares during the last quarter. Jones Financial Companies Lllp boosted its position in shares of Bausch + Lomb by 55.3% during the third quarter. Jones Financial Companies Lllp now owns 9,112 shares of the company’s stock valued at $132,000 after buying an additional 3,246 shares during the period. Focus Partners Wealth bought a new position in shares of Bausch + Lomb during the third quarter valued at approximately $170,000. Mission Wealth Management LP purchased a new stake in shares of Bausch + Lomb in the third quarter worth approximately $210,000. Finally, JPMorgan Chase & Co. purchased a new stake in shares of Bausch + Lomb in the second quarter worth approximately $200,000. 11.07% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, EVP A Robert D. Bailey purchased 14,600 shares of the business’s stock in a transaction dated Friday, March 6th. The shares were acquired at an average cost of $17.15 per share, for a total transaction of $250,390.00. Following the acquisition, the executive vice president owned 231,890 shares of the company’s stock, valued at $3,976,913.50. The trade was a 6.72% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Brent L. Saunders purchased 14,700 shares of the business’s stock in a transaction dated Friday, March 6th. The stock was bought at an average price of $17.14 per share, for a total transaction of $251,958.00. Following the completion of the acquisition, the chief executive officer directly owned 966,575 shares in the company, valued at approximately $16,567,095.50. This trade represents a 1.54% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired 33,300 shares of company stock valued at $570,868 over the last 90 days. Corporate insiders own 0.76% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on BLCO. Citigroup boosted their price objective on Bausch + Lomb from $20.00 to $21.00 and gave the company a “buy” rating in a report on Thursday, February 19th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bausch + Lomb in a research note on Wednesday, January 21st. Barclays lifted their target price on Bausch + Lomb from $17.00 to $20.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 19th. Stifel Nicolaus set a $16.00 target price on shares of Bausch + Lomb in a research note on Thursday, February 19th. Finally, Wall Street Zen cut shares of Bausch + Lomb from a “buy” rating to a “hold” rating in a report on Saturday, February 21st. Four investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Bausch + Lomb presently has an average rating of “Hold” and a consensus target price of $18.25.

Bausch + Lomb Trading Down 3.2%

NYSE BLCO opened at $15.38 on Friday. Bausch + Lomb Corporation has a one year low of $10.45 and a one year high of $18.92. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.04 and a current ratio of 1.55. The company has a market capitalization of $5.46 billion, a price-to-earnings ratio of -15.08, a price-to-earnings-growth ratio of 0.64 and a beta of 0.58. The company’s 50-day simple moving average is $17.02 and its two-hundred day simple moving average is $16.30.

Bausch + Lomb (NYSE:BLCO) last announced its quarterly earnings results on Wednesday, February 18th. The company reported $0.32 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.03). Bausch + Lomb had a positive return on equity of 2.77% and a negative net margin of 7.06%.The business had revenue of $1.41 billion during the quarter, compared to analysts’ expectations of $1.38 billion. During the same period in the previous year, the company posted $0.25 EPS. Bausch + Lomb’s revenue for the quarter was up 9.8% on a year-over-year basis. Equities analysts forecast that Bausch + Lomb Corporation will post 0.74 EPS for the current fiscal year.

Bausch + Lomb Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.